Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Takes $1.25M Milestone in Toppan Microarray Development Deal

NEW YORK, Dec. 2 (GenomeWeb News) - Acacia Research said today that its CombiMatrix microarray subsidiary has received a $1.25 million milestone payment from Toppan as part of a development agreement the companies entered in May.

The companies are co-developing a microarray product suite based on CombiMatrix's electrochemical detection technology. Upon commercialization, Toppan will manufacture microarrays for CombiMatrix or its partners and will share revenues and royalties from sales of the products.

CombiMatrix received an initial $1 million upfront payment from Toppan when the alliance was formed in May.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more